NYSEARCA:IDNA iShares Genomics Immunology and Healthcare ETF (IDNA) Price, Holdings, & News $21.16 -0.34 (-1.58%) Closing price 06/13/2025 04:10 PM EasternExtended Trading$21.20 +0.04 (+0.19%) As of 06/13/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock About iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get IDNA alerts:Sign Up Key Stats Today's Range$21.12▼$21.3450-Day Range$17.92▼$21.5052-Week Range$17.26▼$25.80Volume9,428 shsAverage Volume32,088 shsMarket Capitalization$108.97 millionAssets Under Management$109.20 millionDividend Yield1.04%Net Expense Ratio0.47%Aggregate RatingModerate Buy ETF OverviewThe iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.Read More… iShares Genomics Immunology and Healthcare ETF ExpensesTypeIDNATheme ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.47%0.57%0.57%0.52%0.54%Other Expenses0.00%0.55%0.48%0.56%0.51%Total Expense0.47%0.73%0.72%0.73%0.71%Fee Waiver0.00%-0.69%-0.48%-0.65%-0.54%Net Expense0.47%0.60%0.63%0.58%0.60% Receive IDNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iShares Genomics Immunology and Healthcare ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address IDNA ETF News HeadlinesIDNA: The Cutting Edge Of Medical Science Is A Risky InvestmentApril 20, 2025 | seekingalpha.comIshares Healthcare Innov Ucits Etf Acc Share Price (HEAL.MI)November 7, 2024 | lse.co.ukWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.June 15, 2025 | Crypto Swap Profits (Ad)iShares S&P 500 Health Care Sector UCITS ETF USD (Acc) (IUHC.L)September 25, 2024 | finance.yahoo.comiDNA Genomics Public LtdMay 18, 2024 | morningstar.comiShares Genomics Immunology and Healthcare ETF (IDNA)April 15, 2024 | finance.yahoo.comSee More Headlines IDNA ETF - Frequently Asked Questions How have IDNA shares performed this year? iShares Genomics Immunology and Healthcare ETF's stock was trading at $22.63 on January 1st, 2025. Since then, IDNA shares have decreased by 6.5% and is now trading at $21.16. View the best growth stocks for 2025 here. Who are iShares Genomics Immunology and Healthcare ETF's major shareholders? iShares Genomics Immunology and Healthcare ETF's top institutional investors include Cambridge Investment Research Advisors Inc. (0.37%). How do I buy shares of iShares Genomics Immunology and Healthcare ETF? Shares of IDNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of iShares Genomics Immunology and Healthcare ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that iShares Genomics Immunology and Healthcare ETF investors own include iShares Micro-Cap ETF (IWC), The RMR Group (RMR), Waste Connections (WCN), DiamondRock Hospitality (DRH), AUO (AUOTY), American Water Works (AWK) and Triple Flag Precious Metals (TFPM). Fund Details IssueriShares Fund NameiShares Genomics Immunology and Healthcare ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:IDNA Inception Date6/11/2019 Fund ManagerJennifer Hsui, Greg Savage, Paul Whitehead WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNYSE FactSet Global Genomics and Immuno Biopharma Index CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings63 Fund Statistics Assets Under Management$109.20 million Average Daily Volume$0.00 Discount/Premium-0.04% Administrator, Advisor and Custodian AdministratorState Street Bank and Trust Company AdvisorBlackRock Fund Advisors CustodianState Street Bank and Trust Company DistributorBlackRock Investments, LLC Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerJane Street Options OptionableN/A Short Interest6,700 shs Miscellaneous Outstanding Shares5,150,000Beta0.99 Creation Unit50,000 Creation Fee$850.00 These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report Top 10 IDNA HoldingsBeOne Medicines Ltd.Holding Weight: 6.00%GSK plcHolding Weight: 5.68%Exelixis (NASDAQ:EXEL)Holding Weight: 5.46%Roche Holding AGHolding Weight: 5.30%AstraZeneca PLCHolding Weight: 5.13%Genmab A/SHolding Weight: 4.91%Takeda Pharmaceutical Company LimitedHolding Weight: 4.87%SpringWorks Therapeutics (NASDAQ:SWTX)Holding Weight: 4.83%SanofiHolding Weight: 4.82%Incyte (NASDAQ:INCY)Holding Weight: 4.28%Full Holdings DetailsIDNA Sector ExposureIDNA Industry Exposure This page (NYSEARCA:IDNA) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Genomics Immunology and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Genomics Immunology and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IDNA Stock Free IDNA Stock Alerts